These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6387264)

  • 1. Captopril in Cushing's syndrome.
    Greminger P; Vetter W; Groth H; Lüscher T; Tenschert W; Siegenthaler W; Vetter H
    Klin Wochenschr; 1984 Sep; 62(18):855-8. PubMed ID: 6387264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
    Saruta T; Suzuki H; Handa M; Igarashi Y; Kondo K; Senba S
    J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
    Baba T; Aoyagi K; Murabayashi S; Sasaki K; Nigawara K; Takebe K
    Endocrinol Jpn; 1983 Dec; 30(6):715-21. PubMed ID: 6327249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
    Fallo F; Maragno I; Merola P; Mantero F
    Clin Exp Hypertens A; 1983; 5(3):321-8. PubMed ID: 6340859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
    Yasuda G; Shionoiri H; Umemura S; Takasaki I; Ishii M
    Eur J Endocrinol; 1994 Dec; 131(6):582-8. PubMed ID: 7804440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
    Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. A serial study during pregnancy, lactation and anestrus.
    Olsson K; Fyhrquist F; Benlamlih S; Dahlborn K
    Acta Physiol Scand; 1984 May; 121(1):73-80. PubMed ID: 6377825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic aspects of hypertension in Cushing's syndrome.
    Tenschert W; Baumgart P; Greminger P; Vetter W; Vetter H
    Cardiology; 1985; 72 Suppl 1():84-90. PubMed ID: 3902234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The changes in renin-angiotensin-aldosterone-system in different subtypes of Cushing's syndrome].
    Cui J; Dou J; Yang G; Zang L; Jin N; Chen K; Du J; Gu W; Wang X; Yang L; Lyu Z; Ba J; Mu Y; Lu J; Li J; Pan C
    Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):618-22. PubMed ID: 26359025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive patients on hemodialysis.
    Kaneda H; Murata T; Matsumoto J; Maeta T; Shitomi K; Haruyama T
    Tohoku J Exp Med; 1982 May; 137(1):21-31. PubMed ID: 7048628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of captopril, diuretic and their combination in low- and normal-renin essential hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Koplin JR
    Life Sci; 1982 Jan; 30(1):59-65. PubMed ID: 7033708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension].
    Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T
    Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan in Cushing's syndrome.
    Zacharieva S; Orbetzova M; Natchev E; Vergilova J; Andrewa M; Wipperrnann M; Torbova S; Tzingilev D; Angelova-Gateva P
    Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):163-8. PubMed ID: 9604859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiotensin - converting enzyme in CBA mice with psychosocial hypertension.
    Henry JP; Stephens PM; Vander AJ
    Clin Exp Hypertens A; 1983; 5(1):87-97. PubMed ID: 6299629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
    Vetter W; Vetter H; Beckerhoff R; Redlich B; Cottier P; Siegenthaler W
    Klin Wochenschr; 1976 Jul; 54(14):661-3. PubMed ID: 979066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.